DIA 2013 49th Annual Meeting
Click here to go to the previous page
CDER Town Hall: Part 2 of 2
Track
:
Track 18: Global Regulatory
Program Code:
431
Date:
Thursday, June 27, 2013
Time:
10:45 AM to 12:15 PM
EST
Location:
210B
CHAIR
:
SPEAKER
(S):
John K Jenkins, MD (SPKAGY), Director, Office of New Drugs, CDER, FDA, United States
Christine M. V. Moore, PhD (SPKAGY), Acting Director, Office of New Drug Quality Assessment, OPS, CDER, FDA, United States Gerald J. Dal Pan, MD (SPKAGY), Director, Office of Surveillance and Epidemiology, CDER, FDA, United States Robert T. O'Neill, PhD (SPKAGY), Senior Statistical Advisor, Office of Translational Sciences, CDER, FDA, United States Robert J. Temple, MD (SCHAGY), Deputy Center Director for Clinical Science, CDER, FDA, United States Justina A. Molzon, JD,MPharm (SPKAGY), Associate Center Director for International Programs, CDER, FDA, United States
Description
This is a roundtable discussion with CDER leadership. Topics to be discussed will depend on the interests of the audience. Panel members will discuss and update regulatory changes and the current hot topics at CDER.
Part 1 of this forum will take place Thursday, June 27 at 9:00 am
Part 1 of this forum will take place Thursday, June 27 at 9:00 am
This session is a part of:
This session is a part of: